163 related articles for article (PubMed ID: 28842515)
1. Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.
Zhu H; Chen A; Li S; Tao X; Sheng B; Chetry M; Zhu X
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842515
[TBL] [Abstract][Full Text] [Related]
2. Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.
Zhu H; Tao X; Zhou L; Sheng B; Zhu X; Zhu X
BMC Cancer; 2019 Aug; 19(1):865. PubMed ID: 31470801
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy.
Wang PH; Chang YH; Yang YH; Chang WH; Huang SY; Lai CR; Juang CM; Chen YJ; Horng HC; Wen KC; Ng HT; Yuan CC; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):330-6. PubMed ID: 25286786
[TBL] [Abstract][Full Text] [Related]
4. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy.
Zhang H; Peng W; Zhang Y
J Int Med Res; 2014 Jun; 42(3):641-50. PubMed ID: 24651993
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
Minig L; Zanagnolo V; Cárdenas-Rebollo JM; Colombo N; Maggioni A
Eur J Surg Oncol; 2016 Sep; 42(9):1372-7. PubMed ID: 27247200
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.
Jin L; Shen Q; Ding S; Jiang W; Jiang L; Zhu X
Gynecol Oncol; 2012 Jul; 126(1):140-6. PubMed ID: 22487537
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
[TBL] [Abstract][Full Text] [Related]
8. Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma.
Chen CA; Cheng WF; Wei LH; Su YN; Hsieh CY
J Formos Med Assoc; 2002 Mar; 101(3):195-202. PubMed ID: 12051015
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
[TBL] [Abstract][Full Text] [Related]
10. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.
Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X
Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148
[TBL] [Abstract][Full Text] [Related]
11. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S
Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186
[TBL] [Abstract][Full Text] [Related]
12. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer.
Bolis G; van Zainten-Przybysz I; Scarfone G; Zanaboni F; Scarabelli C; Tateo S; Calabrese M; Parazzini F
Gynecol Oncol; 1996 Oct; 63(1):62-5. PubMed ID: 8898170
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix].
Sláma J; Cibula D; Freitag P; Fischerová D; Janousek M; Pavlista D; Strunová M; Zikán M; Jancárková N
Ceska Gynekol; 2007 Apr; 72(2):116-9. PubMed ID: 17639733
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
